Luis Paz-Ares
ScholarGPS® ID: 25395666006952
Affiliation History
Field
Medicine
Discipline
Oncology
Top Specialties
Cancer | Lung Cancer | Non-small-cell Lung Carcinoma | Thorax | Chemotherapy | Neoplasm | Cisplatin | Epidermal Growth Factor Receptor | Nivolumab | Mutation | Paclitaxel | Erlotinib | Gemcitabine | Docetaxel | Biomarker
Metrics Summary
Publication Count
832
Predicted Citations
75,795
Predicted h-index
102
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Journal of Clinical Oncology, volume 42, issue 17_suppl, pages LBA8500-LBA8500 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 8575-8575 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 8094-8094 (2024). |
DeLLphi-301: Tarlatamab phase 2 trial in small cell lung cancer (SCLC)—Efficacy and safety analyzed by presence of brain metastasis. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 8015-8015 (2024). |
Ipatasertib in patients with AKT1/2/3 mutation-positive ( AKT mut) tumors: TAPISTRY study. (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 3092-3092 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 2533-2533 (2024). |
Efficacy and safety of lurbinectedin (LUR) with irinotecan (IRI) in a phase 2 expansion cohort of patients (Pts) with synovial sarcoma (SS). (journal article) Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 11560-11560 (2024). |
Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS8126-TPS8126 (2024). |
Journal of Clinical Oncology (2024). |
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study (journal article) Molecular Cancer, volume 23, issue 1 (2024). |
Facts and Hopes on Cancer Immunotherapy for Small Cell Lung Cancer (journal article) Clinical Cancer Research (2024). |
Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments (journal article) Drugs, volume 84, issue 5, pages 527-548 (2024). |
Journal of the National Comprehensive Cancer Network, volume 22, issue 2.5 (2024). |
Journal of Thoracic Oncology (2024). |
Lung Cancer, volume 189 (2024). |
Lurbinectedin in patients with small cell lung cancer with chemotherapy-free interval ≥30 days and without central nervous metastases (journal article) Lung Cancer, volume 188 (2024). |
Expert-based collaborative analysis of the situation and prospects of biomarker test implementation in oncology in Spain (journal article) Clinical and Translational Oncology, volume 26, issue 4, pages 985-990 (2024). |
Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial (journal article) Journal of Clinical Oncology, volume 42, issue 2, pages 180-191 (2024). |
Lung Cancer, volume 187 (2024). |